Trials / Completed
CompletedNCT03088917
'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'
'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat' A Prospective Cohort Study Assessing the Impact of Loss to Follow-up on Liver Fibrosis in Chronic Hepatitis C.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 106 (actual)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objective: To coordinate active tracing of chronic hepatitis C patients lost to follow-up to inform them about there disease severity and treatment options. Study design: This is a prospective cohort study, which will start as a pilot study in the Radboudumc Population: lost to follow-up chronic hepatitis C patients in the region Nijmegen. This so-called lost population consists of all patients, that in the past have been identified at the Radboudumc but who are currently lost to or have been withdrawn from follow-up. The time-span of interest will be 2000-2015. We estimate that this project will retrace 100 lost patients through this search.
Conditions
Timeline
- Start date
- 2017-09-27
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2017-03-23
- Last updated
- 2020-02-10
- Results posted
- 2020-02-10
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03088917. Inclusion in this directory is not an endorsement.